Mounjaro KwiKpen Tirzepatide 12.5mg | 4 Doses | Exp. 09/2027

₦1,280,000

Mounjaro (tirzepatide) is an injection administered once weekly that is recognized for promoting weight loss by mimicking GLP-1 and GIP hormones, which helps to reduce appetite and improve satiety. It is approved for type 2 diabetes and often used for weight management, sometimes under the brand name Zepbound.

Guaranteed Safe And Secure Checkout

Description
Reviews(0)

Key Details on Higher-Dose Mounjaro for Weight Loss:

Treatment Progression: Mounjaro treatment typically begins with lower, initial doses, which are gradually increased by a healthcare provider over several weeks to minimize potential side effects.
Effectiveness: Higher dosages are associated with stronger appetite suppression, and they are typically utilized for patients who need additional support for weight management, often after using lower doses for a period.
Side Effects: Common adverse reactions, which may occur more frequently with higher doses, include gastrointestinal issues such as nausea, vomiting, diarrhea, constipation, and abdominal pain.
Usage Context: A reduced-calorie diet and increased physical activity are part of the approach to optimize results and ensure long-term weight management.
Eligibility: These medications are typically considered for individuals with a body mass index (BMI) of 30 or higher, or 27 or higher with weight-related conditions.